Related Scientific Literature
- Evaluation the auxiliary diagnosis value of antibodies assays for detection of novel coronavirus (SARS-Cov-2) causing an outbreak of pneumonia (COVID-19)
- Serological tests facilitate identification of asymptomatic SARS-CoV-2 infection in Wuhan, China
- Detection of IgM and IgG antibodies against SARS-CoV-2 in patients with autoimmune diseases
- Challenges in Laboratory Diagnosis of the Novel Coronavirus SARS-CoV-2
- Evaluation of the auxiliary diagnostic value of antibody assays for the detection of novel coronavirus (SARS-CoV-2)
- Immunological assays for SARS-CoV-2: an analysis of available commercial tests to measure antigen and antibodies
- COVID-19 Serological Tests: How Well Do They Actually Perform?
- In vitro diagnostics of coronavirus disease 2019: Technologies and application
- Clinically practiced and commercially viable nanobio engineered analytical methods for COVID-19 diagnosis
- Antibody tests in detecting SARS-CoV-2 infection: A meta-analysis
- Diagnostic performance of serological assays in the detection of SARS-CoV-2: A review
- Comparison and Application of Different Immunoassay Methods for the Detection of SARS-CoV-2
- Assay Techniques and Test Development for COVID-19 Diagnosis.
- Meta-analysis of the clinical performance of commercial SARS-CoV-2 nucleic acid, antigen and antibody tests up to 22 August 2020
- Clinical validation of an immunochromatographic SARS-Cov-2 IgM/IgG antibody assay with Japanese cohort
- Different longitudinal patterns of nucleic acid and serology testing results based on disease severity of COVID-19 patients
- Evaluation of six commercial mid to high volume antibody and six point of care lateral flow assays for detection of SARS-CoV-2 antibodies
- Overcoming Supply Shortage for SARS-CoV-2 Detection by RT-qPCR.